News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,020 Results
Type
Article (40925)
Company Profile (267)
Press Release (680818)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204673)
Career Advice (2024)
Deals (35533)
Drug Delivery (110)
Drug Development (81385)
Employer Resources (173)
FDA (16416)
Job Trends (14945)
News (346401)
Policy (32729)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2568)
Accelerated approval (34)
Adcomms (24)
Allergies (142)
Alliances (49575)
ALS (170)
Alzheimer's disease (1671)
Antibody-drug conjugate (ADC) (313)
Approvals (16688)
Artificial intelligence (515)
Autoimmune disease (159)
Automation (41)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (192)
Biotechnology (174)
Bladder cancer (158)
Brain cancer (57)
Breast cancer (640)
Cancer (4828)
Cardiovascular disease (402)
Career advice (1709)
Career pathing (36)
CAR-T (283)
CDC (45)
Celiac Disease (2)
Cell therapy (747)
Cervical cancer (36)
Clinical research (69594)
Collaboration (1710)
Company closure (4)
Compensation (1167)
Complete response letters (57)
COVID-19 (2713)
CRISPR (93)
C-suite (855)
Cystic fibrosis (143)
Data (6261)
Decentralized trials (2)
Denatured (25)
Depression (134)
Diabetes (502)
Diagnostics (6698)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (254)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (233)
Earnings (90227)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (117346)
Executive appointments (980)
FDA (19552)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1474)
Gene editing (199)
Generative AI (43)
Gene therapy (597)
GLP-1 (966)
Government (4663)
Grass and pollen (6)
Guidances (384)
Healthcare (18878)
HIV (60)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (254)
Immuno-oncology (57)
Indications (115)
Infectious disease (2987)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (118)
Intellectual property (254)
Interviews (315)
IPO (16643)
IRA (50)
Job creations (3642)
Job search strategy (1428)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (547)
Leadership (32)
Legal (7951)
Liver cancer (91)
Longevity (14)
Lung cancer (652)
Lymphoma (379)
Machine learning (42)
Management (59)
Manufacturing (802)
MASH (164)
Medical device (13774)
Medtech (13828)
Mergers & acquisitions (19966)
Metabolic disorders (1271)
Multiple sclerosis (163)
NASH (16)
Neurodegenerative disease (319)
Neuropsychiatric disorders (88)
Neuroscience (2909)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4515)
Now hiring (67)
Obesity (597)
Opinion (261)
Ovarian cancer (166)
Pain (198)
Pancreatic cancer (228)
Parkinson's disease (281)
Partnered (33)
Patents (505)
Patient recruitment (494)
Peanut (56)
People (58891)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21694)
Phase 2 (30627)
Phase 3 (22819)
Pipeline (5383)
Policy (284)
Postmarket research (2564)
Preclinical (9200)
Press Release (64)
Prostate cancer (238)
Psychedelics (48)
Radiopharmaceuticals (282)
Rare diseases (841)
Real estate (5954)
Recruiting (70)
Regulatory (24526)
Reports (53)
Research institute (2389)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (79)
Schizophrenia (148)
Series A (240)
Series B (190)
Service/supplier (11)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3615)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (1012)
Venture capital (89)
Weight loss (381)
Women's health (92)
Worklife (18)
Date
Today (160)
Last 7 days (583)
Last 30 days (2251)
Last 365 days (29955)
2026 (3749)
2025 (30172)
2024 (35216)
2023 (40075)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39232)
Australia (6413)
California (11349)
Canada (3302)
China (1102)
Colorado (479)
Connecticut (480)
Delaware (339)
Europe (84569)
Florida (1704)
Georgia (358)
Hawaii (3)
Idaho (61)
Illinois (865)
India (67)
Indiana (524)
Iowa (22)
Japan (433)
Kansas (127)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1387)
Massachusetts (8117)
Michigan (326)
Minnesota (630)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (3014)
New Mexico (28)
New York (2990)
North Carolina (1461)
North Dakota (8)
Northern California (5548)
Ohio (334)
Oklahoma (21)
Oregon (41)
Pennsylvania (2290)
Puerto Rico (24)
Rhode Island (48)
South America (1108)
South Carolina (66)
South Dakota (1)
Southern California (4422)
Tennessee (176)
Texas (1750)
United States (40214)
Utah (337)
Vermont (1)
Virginia (264)
Washington D.C. (81)
Washington State (923)
West Virginia (4)
Wisconsin (110)
Wyoming (2)
722,020 Results for "xilis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Xilis Announces Formation of its Scientific Advisory Board
Xilis today announced the addition of four members to its newly formed Scientific Advisory Board (SAB).
December 15, 2022
·
5 min read
Business
Xilis and MD Anderson Announce Strategic Collaboration to Advance Novel Technology and Accelerate Therapeutic Development
Xilis and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration to deploy Xilis’s proprietary MicroOrganoSphere™ (MOS) technology in support of preclinical research to accelerate the development of novel cancer therapies.
February 15, 2023
·
5 min read
Bio NC
Xilis Participates in €325MM Oncode-PACT Consortium to Accelerate the Development of Cancer Drugs
Xilis, Inc. announced that it is participating in the recently announced public-private Oncode-PACT.
May 3, 2022
·
4 min read
Press Releases
BioSyent to Acquire Oral Science Inc.
February 9, 2026
·
10 min read
Bio NC
Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million
Xilis, Inc., a pioneering biotechnology company developing its MicroOrganoSphere™ (MOS™) technology to guide precision therapy for cancer patients and accelerate drug discovery and development, has closed an extension of over US$19 million to its Series A financing round, bringing the total amount raised to over US$89 million.
July 13, 2022
·
4 min read
Business
Xilis Announces Breast Cancer Oncologist Dr. Daniel F. Hayes to Join Clinical Advisory Board
Xilis expands CAB to five members to help company develop its MicroOrganoSphere™ technology.
June 8, 2022
·
4 min read
Press Releases
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
February 18, 2026
·
5 min read
Press Releases
Axogen, Inc. to Participate in Multiple Upcoming March 2026 Investor Conferences
February 17, 2026
·
1 min read
Press Releases
BrightSpring Health Services, Inc. to Host Investor Day on March 17, 2026
February 18, 2026
·
1 min read
Press Releases
Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.
February 10, 2026
·
2 min read
1 of 72,202
Next
